A bioprocessing conference and exhibition focused on advancing biopharmaceutical development and manufacturing. Across four ...

Latin America will need to overhaul how it budgets and finances healthcare if it is to strengthen health systems by 2026 and ...

The age-related macular degeneration (AMD) market in the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK ...

Enhertu (trastuzumab deruxtecan) has now been approved in China for the treatment of adult patients with unresectable or ...

Biocon Biologics, a fully integrated global biosimilars company and subsidiary of India’s Biocon Ltd, announced that it has ...

The inauguration of Japanese drug major Takeda's new, state-of-the-art filling line at its Neuchâtel, Switzerland, production ...

Indian drugmaker Biocon has announced the signing of an out-licensing agreement with Ajanta Pharma to market its vertically ...

This month, Samsung Bioepis announced the European launch of Obodence (60 mg pre-filled syringe) and Xbryk (120 mg vial), ...

Against the backdrop of a turbulent year marked by both breakthrough and setbacks, the biopharmaceutical industry is entering ...

The share of imported drugs in the Russian pharmaceutical market should significantly decline over the next six years, while ...

A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...

Despite the US Food and Drug Administration’s (FDA) acceptance of Inovio’s Biologics License Application (BLA) for INO-3107 for review as a potential treatment for adults with recurrent respiratory ...